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energy and 72.72 kJ/M energy was used in case of osteoarthritic
samples. Loss of water content in all three groups are presented
with a sharp step on the TG curve, starting on average tempera-
ture of 37 °C and ending at 116 °C. Linear part of the TG curve
begun at around 62 °C and ended at around 112 °C. loss. In
case of the normal hyaline cartilage 1.266%/1°C fluid loss was
detected. In necrotic samples 1.689%/1 °C decrease in mass
was observed. In the osteoarthritic 1.422%/1 °C mass reduction
was measured
Conclusions: Increase in the cartilage matrix water content in all
cases of degenerative articular cartilage was observed. Based on
the results it can be stated that water content is higher in impaired
samples, meanwhile water interstitial bonding was stronger in
these cases. Activation energy correlated considerably with water
content in the samples. The newly established thermogravimetric
protocol was sufficient for compositional thermoanalytical study
of normal and degenerative human hyaline cartilage. Previously,
this method has not been used for this purpose. Characterization
of the altered metabolism in cartilage that promote disease
progression should lead to future treatment options that can
prevent structural damage. Therapeutic steps can be adequately
tested and monitored with thermogravimetric measurements.
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Purpose: Cathepsin K is expressed in normal and osteoarthritic
(OA) hyaline cartilage and is capable of cleaving type II collagen
as well as other matrix molecules. The aim of this study was to
determine whether there is evidence for cathepsin K- mediated
cleavage of type II collagen in human OA cartilage.
Methods: Femoral condylar cartilages removed at arthroplasty
for knee OA were cultured in serum-free medium in the presence
and absence of a synthetic cathepsin K inhibitor (supplied by
Merck Frosst, Montreal, Quebec, Canada). The content of a new
type II collagen cleavage neoepitope that can be generated by
cathepsin K was measured by ELISA assay. Aggrecan degrada-
tion was measured by the release of glycosaminoglycan using a
colorimetric assay. Inhibitor toxicity was assessed by measuring
the incorporation of [3H] proline in cartilage cultured with and
without the inhibitor. Type II collagen cleavage was also detected
by ELISA and immunohistochemically in uncultured cartilages
from both normal and OA knee joints.
Results: Cleavage of type II collagen was significantly enhanced
in OA cartilage compared with healthy cartilage, as demonstrated
by ELISA and immunolocalization. The inhibitor reduced collagen
cleavage in cultures of 4 out of 8 patients, this being significant
in 3 cases. There was no effect on proteoglycan release and the
incorporation of tritiated proline was unaffected by the inhibitor.
Conclusions: These results show that cleavage of type II colla-
gen at a site cleaved by cathepsin K is increased in OA articular
cartilages. Based on the specificity and lack of detectable tox-
icity of the inhibitor, this cleavage is due in part to cathepsin
K in almost half of the patients. Cathepsin K should therefore
be considered as a potential therapeutic target in the control of
cartilage degeneration in OA.
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Purpose: The current study examines whether porcine, bovine
and ichthyic chondroitin sulfate (CS) would influence the produc-
tion of nitric oxide (NO) and apoptosis in human osteoarthritic
(OA) chondrocytes. Then, we confirm these results and explain
them by a proposed novel activity concept of CS evaluated by
molecular modeling.
Methods: Samples of human OA articular cartilage were ob-
tained from patients undergoing knee arthroscopy. Firstly, OA
human chondrocytes were incubated with porcine, bovine and
ichthyic CS (100μg/mL) and stimulated with human recombinant
Interleukin-1 beta (hrIL-1 beta) (10ng/mL), in the same time, to
induce NO synthesis. NO release was measured as nitrite con-
centration in 24 and 48 hours culture supernatants by using the
Griess reaction. Secondly, OA human chondrocytes were incu-
bated with porcine, bovine and ichthyic CS during 72 hours and
stimulated by various concentrations SNP (Sodium Nitroprus-
side) during 18 hours. SNP was used as a NO compound donor.
To access the degree of apoptosis, APOPercentage Apoptosis
Assay was used. This finding was further quantitatively confirmed
by fluorescent microscopy using two apoptosis markers: TUNEL
assay and Annexin-V fluos. In the third time, we modelized sev-
eral CS oligosaccharides and we have tested their possibilities
of interaction with IL-1 beta and its receptor.
Results: Bovine, porcine and ichthyic CS tested decreased
significantly NO synthesis at 48 hours when human OA chon-
drocytes were cotreated with CS and hrIL-1beta. However, a
preventive treatment with bovine, porcine and ichthyic CS dur-
ing 72 hours and a stimulation with hrIL-1beta did not reduce
significantly NO synthesis.
In OA chondrocytes treated with bovine, porcine and ichthyic
CS, on average 18% of chondrocytes showed apoptotic features
compared with 31% in chondrocytes treated with SNP. These
data suggest that CS or CS oligosaccharides could interact with
IL-1beta. The modeling study proposed two sites of interactions
between IL-1 beta and some oligosaccharides. We have probed
the specificity of this protein for distinct sulphatation sequences.
Conclusions: These results suggest that bovine, porcine and
ichthyic CS prevent IL-1beta induced increase in NO production.
This preliminary study suggests that bovine, porcine and ichthyic
CS could downregulate apoptosis in the OA chondrocytes. A
decrease of IL-1 beta effects could be the consequence of
specific binding to oligosaccharides.
This study provides a plausible mechanism for the chondropro-
tective properties of bovine, porcine and ichthyic CS.
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Purpose: In early osteoarthritis (OA), hypertrophic chondrocytes
are part of the pathology and are distributed throughout the
